We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Human Genome Sciences, Inc. (MM) | NASDAQ:HGSI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.24 | 0 | 01:00:00 |
GlaxoSmithKline PLC (GSK, GSK.LN) is in talks to acquire Human Genome Sciences Inc. (HGSI) in a $2.6 billion deal, Reuters reports on its website Sunday, citing "sources familiar with the situation."
Citing one of the sources, Reuters reported that GlaxoSmithKline could sweeten the deal slightly, and that an announcement could come as early as Monday.
A spokesman from GlaxoSmithKline declined to comment, Reuters said, adding Human Genome Sciences officials were not immediately available.
Full story at http://www.reuters.com/article/2012/07/15/us-humangenome-glaxosmithkline-idUSBRE86E08P20120715
-Write to copydesk@dowjones.com
1 Year Human Genome Sciences Chart |
1 Month Human Genome Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions